Tumors Metastatic to Brain Withdrawn Phase 1 Trials for Vemurafenib (DB08881)

IndicationStatusPhase
DBCOND0029875 (Tumors Metastatic to Brain)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02145910Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain MetastasesTreatment